Literature DB >> 2567002

Localization of preferential sites of rearrangement within the BCR gene in Philadelphia chromosome-positive acute lymphoblastic leukemia.

C T Denny1, N P Shah, S Ogden, C Willman, T McConnell, W Crist, A Carroll, O N Witte.   

Abstract

The Philadelphia chromosome associated with acute lymphoblastic leukemia (ALL) has been linked to a hybrid BCR/ABL protein product that differs from that found in chronic myelogenous leukemia. This implies that the molecular structures of the two chromosomal translocations also differ. Localization of translocation breakpoints in Philadelphia chromosome-positive ALL has been impeded due to the only partial characterization of the BCR locus. We have isolated the entire 130-kilobase BCR genomic locus from a human cosmid library. A series of five single-copy genomic probes from the 70-kilobase first intron of BCR were used to localize rearrangements in 8 of 10 Philadelphia chromosome-positive ALLs. We have demonstrated that these breakpoints are all located at the 3' end of the intron around an unusual restriction fragment length polymorphism caused by deletion of a 1-kilobase fragment containing Alu family reiterated sequences. This clustering is unexpected in light of previous theories of rearrangement in Philadelphia chromosome-positive chronic myelogenous leukemia that would have predicted a random dispersion of breakpoints in the first intron in Philadelphia chromosome-positive ALL. The proximity of the translocation breakpoints to this constitutive deletion may indicate shared mechanisms of rearrangement or that such polymorphisms mark areas of the genome prone to recombination.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2567002      PMCID: PMC287429          DOI: 10.1073/pnas.86.11.4254

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  44 in total

1.  Translocation of oncogene c-sis from chromosome 22 to chromosome 11 in a Ewing sarcoma-derived cell line.

Authors:  A G van Kessel; C Turc-Carel; A de Klein; G Grosveld; G Lenoir; D Bootsma
Journal:  Mol Cell Biol       Date:  1985-02       Impact factor: 4.272

2.  Letter: A new consistent chromosomal abnormality in chronic myelogenous leukaemia identified by quinacrine fluorescence and Giemsa staining.

Authors:  J D Rowley
Journal:  Nature       Date:  1973-06-01       Impact factor: 49.962

3.  Plasmid screening at high colony density.

Authors:  D Hanahan; M Meselson
Journal:  Methods Enzymol       Date:  1983       Impact factor: 1.600

Review 4.  Repetitive sequences in eukaryotic DNA and their expression.

Authors:  W R Jelinek; C W Schmid
Journal:  Annu Rev Biochem       Date:  1982       Impact factor: 23.643

5.  Molecular cloning of a 5' segment of the genomic phl gene defines a new breakpoint cluster region (bcr2) in Philadelphia-positive acute leukemias.

Authors:  S J Chen; Z Chen; J D Grausz; J Hillion; L d'Auriol; G Flandrin; C J Larsen; R Berger
Journal:  Leukemia       Date:  1988-10       Impact factor: 11.528

6.  Cell lines and clinical isolates derived from Ph1-positive chronic myelogenous leukemia patients express c-abl proteins with a common structural alteration.

Authors:  J B Konopka; S M Watanabe; J W Singer; S J Collins; O N Witte
Journal:  Proc Natl Acad Sci U S A       Date:  1985-03       Impact factor: 11.205

7.  Philadelphia chromosomal breakpoints are clustered within a limited region, bcr, on chromosome 22.

Authors:  J Groffen; J R Stephenson; N Heisterkamp; A de Klein; C R Bartram; G Grosveld
Journal:  Cell       Date:  1984-01       Impact factor: 41.582

8.  Localization of the c-ab1 oncogene adjacent to a translocation break point in chronic myelocytic leukaemia.

Authors:  N Heisterkamp; J R Stephenson; J Groffen; P F Hansen; A de Klein; C R Bartram; G Grosveld
Journal:  Nature       Date:  1983 Nov 17-23       Impact factor: 49.962

9.  An alteration of the human c-abl protein in K562 leukemia cells unmasks associated tyrosine kinase activity.

Authors:  J B Konopka; S M Watanabe; O N Witte
Journal:  Cell       Date:  1984-07       Impact factor: 41.582

10.  Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease.

Authors:  J M Chirgwin; A E Przybyla; R J MacDonald; W J Rutter
Journal:  Biochemistry       Date:  1979-11-27       Impact factor: 3.162

View more
  9 in total

1.  Structural alterations of the BCR and ABL genes in Ph1 positive acute leukemias with rearrangements in the BCR gene first intron: further evidence implicating Alu sequences in the chromosome translocation.

Authors:  S J Chen; Z Chen; M P Font; L d'Auriol; C J Larsen; R Berger
Journal:  Nucleic Acids Res       Date:  1989-10-11       Impact factor: 16.971

2.  BCR first exon sequences specifically activate the BCR/ABL tyrosine kinase oncogene of Philadelphia chromosome-positive human leukemias.

Authors:  A J Muller; J C Young; A M Pendergast; M Pondel; N R Landau; D R Littman; O N Witte
Journal:  Mol Cell Biol       Date:  1991-04       Impact factor: 4.272

Review 3.  Chronic myeloid leukemia: pathophysiology, diagnostic parameters, and current treatment concepts.

Authors:  Christian Sillaber; Matthias Mayerhofer; Hermine Agis; Verena Sagaster; Christine Mannhalter; Wolfgang R Sperr; Klaus Geissler; Peter Valent
Journal:  Wien Klin Wochenschr       Date:  2003-08-14       Impact factor: 1.704

4.  Human transcription factor IIIC box B binding subunit.

Authors:  N D L'Etoile; M L Fahnestock; Y Shen; R Aebersold; A J Berk
Journal:  Proc Natl Acad Sci U S A       Date:  1994-03-01       Impact factor: 11.205

5.  Characterization of the BCR promoter in Philadelphia chromosome-positive and -negative cell lines.

Authors:  N P Shah; O N Witte; C T Denny
Journal:  Mol Cell Biol       Date:  1991-04       Impact factor: 4.272

6.  Isolation and characterization of the human nucleophosmin/B23 (NPM) gene: identification of the YY1 binding site at the 5' enhancer region.

Authors:  P K Chan; F Y Chan; S W Morris; Z Xie
Journal:  Nucleic Acids Res       Date:  1997-03-15       Impact factor: 16.971

7.  Fine mapping of chromosome 22 breakpoints within the breakpoint cluster region (bcr) implies a role for bcr exon 3 in determining disease duration in chronic myeloid leukemia.

Authors:  A Grossman; R T Silver; Z Arlin; M Coleman; E Camposano; P Gascon; P A Benn
Journal:  Am J Hum Genet       Date:  1989-11       Impact factor: 11.025

Review 8.  Molecular mechanisms of cancer.

Authors:  H P Koeffler; F McCormick; C Denny
Journal:  West J Med       Date:  1991-11

9.  Chromosomal translocations joining LCK and TCRB loci in human T cell leukemia.

Authors:  B Tycko; S D Smith; J Sklar
Journal:  J Exp Med       Date:  1991-10-01       Impact factor: 14.307

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.